Daniel P. Van Plew - Nov 15, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/** Daniel P. Van Plew
Stock symbol
REGN
Transactions as of
Nov 15, 2021
Transactions value $
-$9,380,857
Form type
4
Date filed
11/17/2021, 03:02 PM
Previous filing
Aug 10, 2021
Next filing
Dec 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $6.76M +25K +92.83% $270.43 51.9K Nov 15, 2021 Direct
transaction REGN Common Stock Tax liability -$11.7M -18.2K -35.09% $641.50 33.7K Nov 15, 2021 Direct
transaction REGN Common Stock Sale -$344K -528 -1.57% $652.20 33.2K Nov 16, 2021 Direct F1
transaction REGN Common Stock Sale -$549K -840 -2.53% $653.41 32.3K Nov 16, 2021 Direct F2
transaction REGN Common Stock Sale -$824K -1.26K -3.9% $654.33 31.1K Nov 16, 2021 Direct F3
transaction REGN Common Stock Sale -$229K -350 -1.13% $655.03 30.7K Nov 16, 2021 Direct F4
transaction REGN Common Stock Sale -$131K -200 -0.65% $657.18 30.5K Nov 16, 2021 Direct F5
transaction REGN Common Stock Sale -$459K -697 -2.28% $658.50 29.8K Nov 16, 2021 Direct F6
transaction REGN Common Stock Sale -$1.58M -2.4K -8.05% $659.42 27.4K Nov 16, 2021 Direct F7
transaction REGN Common Stock Sale -$330K -500 -1.82% $660.51 26.9K Nov 16, 2021 Direct F8
holding REGN Common Stock 1.05K Nov 15, 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -25K -100% $0.00* 0 Nov 15, 2021 Common Stock 25K $270.43 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 528 shares of Company stock on November 16, 2021 at prices ranging from $652.01 to $652.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F2 Represents volume-weighted average price of sales of 840 shares of Company stock on November 16, 2021 at prices ranging from $653.03 to $653.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 1,260 shares of Company stock on November 16, 2021 at prices ranging from $654.03 to $654.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 350 shares of Company stock on November 16, 2021 at prices ranging from $655.01 to $655.07. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 200 shares of Company stock on November 16, 2021 at prices ranging from $657.09 to $657.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 697 shares of Company stock on November 16, 2021 at prices ranging from $658.03 to $658.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 2,403 shares of Company stock on November 16, 2021 at prices ranging from $659.01 to $659.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 500 shares of Company stock on November 16, 2021 at prices ranging from $660.33 to $660.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F9 The stock option award vests in four equal annual installments, commencing one year after the date of grant.